GlassScriptPhysician profile
Blaise Milburn
NPI 1902244627
$2,418.92
in general payments reported to CMS, 2019-2025
17 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.24 · 2020: $1,140 · 2021: $99.85 · 2023: $314 · 2024: $440 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,270.89 | 2020-2023 | Da Vinci Surgical System |
| Baxter Healthcare | $301.96 | 2023-2025 | Seprafilm, Perclot, Adept |
| Olympus America INC. | $259.18 | 2021-2025 | Olympus, 4k Camera Head, Visera 4k Uhd Camera Control Unit |
| Boston Scientific Corporation | $100.35 | 2023 | Acupulse Duo |
| Ethicon US, LLC | $99.90 | 2024 | Dermabond Prineo, Vicryl, Vistaseal |
| Sage Therapeutics, LLC | $86.35 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $54.33 | 2019 | |
| Amgen INC. | $53.17 | 2025 | Evenity |
| Astellas Pharma US INC | $37.46 | 2025 | Veozah |
| Mayne Pharma Commercial LLC | $26.00 | 2024 | |
| Smith+Nephew, INC. | $23.92 | 2024 | Stravix Pl |
| Millicent US INC | $23.73 | 2025 | Intrarosa, Femlyv |
| Daiichi Sankyo INC. | $21.91 | 2019 | |
| Minerva Surgical, INC | $19.79 | 2024 | |
| Hologic Sales and Service, LLC | $14.29 | 2023 | Coolseal Generator, Fluent Fluid Management System, Acessa Provu System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $13.91 | 2024 | NP Thyroid 60 |
| Meditrina | $11.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaise Milburn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.